Promising Early Results in Solid Tumor Trial
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
False
Advertisement
Latest
Malaria Vaccine Development: Oxford and ReciBioPharm Extend Manufacturing Deal
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
Breaking Down the Data Walls
By Patrick Hyett
November 10, 2025
Pharma must break down data silos to power autonomy, speed, and improved product quality.
3 min read
Roving Reporter Asks: What’s the Most Exciting Research in CGT?
November 7, 2025
Experts discuss in vivo CAR T cell therapy, gene therapies for CNS diseases, personalized cancer vaccines and more.
1 min read
Integrity and Industry: Balancing Purpose and Profit
November 6, 2025
An invitation to our readers to feed back on our content
1 min read
George Tidmarsh: FDA Resignation and Lawsuit
November 5, 2025
Tidmarsh reportedly resigns from FDA and Aurinia Pharmaceuticals files lawsuit
2 min read
From the Apollo Era to the World's First Cell Therapy: Sitting Down With Bruce Levine
November 5, 2025
Bruce Levine shares his journey from a childhood steeped in science to co-founding the first CAR T-cell trials, and explains why communication and regulatory collaboration are crucial for the field’s future.
7 min read
Why ‘Good Enough’ is Not Acceptable in CRO Partnerships
By Stephen Corson
November 5, 2025
Clinical trials are becoming more complex. And not all CROs are able to step up.
3 min read
Supply Chains and the Next Black Swan Event
By Niklas Adamsson
November 4, 2025
Are pharma logistics and supply chains ready for the next test?
8 min read
Overcoming the Static Sales Cycle
November 4, 2025
For decades, pharma sales strategies have been built on static lists and old data. Now, AI-driven models are replacing guesswork with live insights
8 min read
